Related Experiment Video
Updated: Jul 11, 2026
06:57
Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice
Published on: April 10, 2026
Pancreatic islet cell transplantation: update and new developments
Nicholas Onaca1, Bashoo Naziruddin, Shinichi Matsumoto
1Transplant Services, Baylor Regional Transplant Institute, Baylor University Medical Center, Dallas, TX 75246, USA. nicholao@baylorhealth.edu
Summary
Pancreatic islet cell transplantation offers an alternative for type 1 diabetes patients with severe hypoglycemia. While long-term insulin independence is challenging, persistent graft function improves glucose control and prevents dangerous low blood sugar events.
Area of Science:
- Endocrinology
- Transplantation Immunology
- Metabolic Diseases
Background:
- Pancreatic islet cell transplantation is a potential treatment for type 1 diabetes, particularly for those with problematic hypoglycemia.
- Current protocols show high initial success rates for insulin independence (around 80% at 1 year), but long-term sustainability is limited (10% at 5 years).
Purpose of the Study:
- To evaluate the long-term efficacy of pancreatic islet cell transplantation in managing type 1 diabetes.
- To explore the role of islet autotransplantation in patients undergoing total pancreatectomy for chronic pancreatitis.
Main Methods:
- Review of existing data on pancreatic islet cell transplantation outcomes.
- Analysis of islet autotransplantation procedures for chronic pancreatitis patients.
Main Results:
- While 5-year insulin independence rates are low, sustained graft function post-transplantation leads to improved glycemic control and reduced hypoglycemic events.
- Islet autotransplantation can prevent or improve glucose control in patients with chronic pancreatitis requiring pancreatectomy.
Conclusions:
- Improvements in organ preservation, islet isolation techniques, and immunosuppression are crucial for enhancing future transplant outcomes.
- Pancreatic islet transplantation, even without complete insulin independence, provides significant clinical benefits for type 1 diabetes management. Islet autotransplantation is a viable option for specific surgical patient groups.
